INTRODUCTION
============

Embryonic loss reaches up to approximately 20% by day (D) 20 of pregnancy in pigs ([@b4-ajas-25-8-1102-7]). The most critical period in pigs is considered to be D12 of pregnancy, the time when implantation of the conceptus (embryo/fetus and associated extraembryonic membranes) begins and maternal recognition of pregnancy occurs via estrogen secretion by the conceptus ([@b2-ajas-25-8-1102-7]; [@b13-ajas-25-8-1102-7]). It has been suggested that asynchrony of embryo development and inappropriate interactions between the conceptus and the uterine endometrium are major reasons for embryonic mortality during early pregnancy ([@b16-ajas-25-8-1102-7]). Thus, to increase the rate of successful pregnancies, it is essential to understand the mechanism of the establishment of pregnancy.

The implantation process is a well-coordinated interaction between the developing conceptus and the maternal uterus ([@b16-ajas-25-8-1102-7]). At the time of implantation, the conceptus produces estrogen, which acts as a signal for maternal recognition of pregnancy in pigs ([@b3-ajas-25-8-1102-7]). It has been suggested that estrogen reorients prostaglandin F~2α~ (PGF~2α~) secretion from an endocrine to an exocrine manner and exerts an anti-luteolytic action ([@b48-ajas-25-8-1102-7]). In addition to estrogen, the conceptus produces cytokines, such as interleukin (IL)-1β, interferon (IFN)-γ and IFN-δ, growth factors, and proteases ([@b52-ajas-25-8-1102-7]; [@b16-ajas-25-8-1102-7]; [@b32-ajas-25-8-1102-7]; [@b44-ajas-25-8-1102-7]). In response to these factors, the uterine endometrium undergoes dramatic morphological and functional changes to become receptive to the developing conceptus.

In the presence of a conceptus during early pregnancy, the expressions of several genes in the uterine endometrium are known to change. For example, fibroblast growth factor 7 (*FGF7*) is abundantly expressed in uterine endometrial epithelial cells during early pregnancy and is increased by estrogen treatment in endometrial explant cultures ([@b25-ajas-25-8-1102-7]). Secreted phosphoprotein 1 (SPP1, or osteopontin), which binds to integrin receptors and functions in cell-to-cell attachment, is localized to endometrial luminal epithelial cells during early pregnancy and is induced by estrogen ([@b12-ajas-25-8-1102-7]; [@b55-ajas-25-8-1102-7]). In addition, lysophosphatidic acid receptor 3 (*L PAR3*), which is a receptor for lysophosphatidic acid that possesses a growth factor-like activity, is expressed in uterine endometrial epithelial cells during early pregnancy and is induced by estrogen ([@b47-ajas-25-8-1102-7]). Although it has been studied on the expression of many genes in the uterine endometrium during the estrous cycle and pregnancy, the pattern of global gene expression in the uterine endometrium in response to the presence of the conceptus has not been completely determined in pigs.

There have been many efforts to understand the expression and function of the uterine endometrial genes responsible for the establishment and maintenance of pregnancy using various gene expression analysis techniques in pigs. Suppression subtractive hybridization (SHH) has been used to determine novel gene expressions in Meishan-Landrace conceptuses and endometrial tissues at D15 of pregnancy ([@b54-ajas-25-8-1102-7]). In a recent study, we characterized several differentially expressed genes in the uterine endometrium on D12 of the estrous cycle and pregnancy using an annealing control primer (ACP)-based PCR (ACP-PCR) technique ([@b24-ajas-25-8-1102-7]). Microarray technology has also been used to analyze gene expression in uterine endometrial tissues on D30 ([@b23-ajas-25-8-1102-7]) or in cyclic uterine endometrium in pigs ([@b31-ajas-25-8-1102-7]; [@b57-ajas-25-8-1102-7]; [@b20-ajas-25-8-1102-7]). However, there are limited reports that have measured the global expression of genes in the uterine endometrium during embryo implantation in pigs.

Therefore, this study aimed to determine the global expression of uterine genes at the time of embryo implantation using a microarray technique in order to identify differentially expressed genes in the uterine endometrium on D12 and D15 of both the estrous cycle and of pregnancy. We compared microarray data from D12 and D15 of pregnancy to those from D12 and D15 of the estrous cycle and identified pregnancy-related variations in the patterns of global gene expression.

MATERIALS AND METHODS
=====================

Animals and tissue preparation
------------------------------

All experimental procedures involving animals were conducted in accordance with the Guide for Care and Use of Research Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Yonsei University. Crossbred sexually matured gilts that were either not mated or were mated with fertile boars after the onset of estrus were assigned to the D12 or D15 estrous cycle groups or the D12 or D15 pregnancy groups, respectively (n = 3 per d/status). Pregnancy was confirmed by the presence of an apparently normal conceptus in uterine flushings. Endometrium dissected from the myometrium was collected from the middle portion of the uterine horn. Endometrial tissues were snap-frozen in liquid nitrogen and stored at −80°C for RNA extraction.

RNA isolation
-------------

Total RNA from endometrial tissues was extracted using TRIzol (Invitrogen, Carlsbad, CA, USA) and the RNeasy Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. The purity and integrity of the total RNA were checked using NanoDrop (NanoDrop Technologies, Wilmington, DE, USA) and Experion (Bio-rad, Hercules, CA, USA), respectively.

Microarray analysis
-------------------

Five micrograms of total RNA were used for labeling. Probe synthesis from the total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix Inc. (Santa Clara, CA, USA). Briefly, cDNA was synthesized from total RNA using the One-Cycle cDNA Synthesis Kit (Affymetrix). Single-stranded cDNA was synthesized using Superscript II reverse transcriptase and T7-oligo primers at 42°C for 1 h Double-stranded (ds)-cDNA was obtained using DNA ligase, DNA polymerase I, and RNase H at 16°C for 2 h, followed by T4 DNA polymerase at 16°C for 5 min for gap filling. After clean-up with a Sample Cleanup Module (Affymetrix), ds-cDNA was used for *in vitro* transcription (IVT). cDNA was transcribed using the GeneChip IVT Labeling Kit (Affymetrix) in the presence of biotin-labeled CTP and UTP. Ten micrograms of labeled cRNA were fragmented to 35--200 bp using fragmentation buffer (Affymetrix). Fragmented cRNA was hybridized to the porcine genome (Affymetrix) at 45°C for 16 h according to the Affymetrix standard protocol. After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25**°**C followed by a stringent wash buffer at 50°C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix) controlled by GeneChip Operating Software (Affymetrix).

Data analysis
-------------

Expression profiles were analyzed using GeneChip Operating Software (Affymetrix) to identify changes in expression levels in the uterine endometrium during the estrous cycle and early pregnancy. The operating software determined absolute analysis metrics (Detection, Detection p-value) using the scanned probe array data and compared the results between the different treatment group signals to generate the Change, Change p-value, and Signal log ratio (fold change) metrics after pre-processing of the raw data using the MAS5 algorithm. For normalization, data from each expression array were scaled to normalize the overall fluorescence intensity across each chip (average target intensity set at 500). The one-sided Wilcoxon's signed rank test was employed to generate the detection p-value (p\< 0.05). Two sets of algorithms were generated and used to determine change significance and change quantity metrics for every probe set. The change algorithm generated a Change p-value and an associated fold-change value, while the second algorithm gave a quantitative estimate of the change in gene expression in the form of the Signal log ratio. In the present study, the level of gene expression was considered to be increased if the Change p-value was less than 0.0025 and was considered to be decreased if the Change p-value was greater than 0.9975. Only relative changes equal to or greater than that of a two-fold level of expression were considered. We considered genes that matched the established Change p-value and the fold-change value to be differentially expressed genes. Probe identification was obtained using the gene ontology mining tool NetAffx (<http://www.affymetrix.com/analysis/index.affx>) and human homologues ([@b51-ajas-25-8-1102-7]).

Functional annotation clustering analysis
-----------------------------------------

To evaluate biological functions of differentially expressed genes affected by pregnancy status in the uterine endometrium, we conducted functional annotation clustering analysis throughout DAVID program (Database for Annotation, Visualization, and Integrated Discovery, <http://david.niaid.nih.gov/david/version2/index.htm>) ([@b19-ajas-25-8-1102-7]). Official gene symbols of differentially expressed genes were submitted to DAVID for analysis of functional annotation clusters. Functional annotation clusters were determined by gathering related Gene Ontology (GO) terms with respect to biological process, cellular component, and molecular function. Because of limited number of annotated genes for porcine genome in NetAffx resulting from the limited availability of full-length porcine cDNA sequence, we used human gene symbols annotated for the Affymetrix porcine genome microarray probe identifications for the genes whose annotation was not available in NetAffx, as described in [@b51-ajas-25-8-1102-7]. Functional annotation clustering analysis using porcine and human gene symbols in DAVID program was conducted at highest stringency to clarify biological function of DEGs in the uterine endometrium. Functional groups were ordered by their overall enrichment score for the group based on the EASE scores of each term annotated.

Quantitative real-time RT-PCR
-----------------------------

To analyze levels of selected differentially expressed gene mRNAs in the uterine endometrium on D12 and D15 of the estrous cycle and pregnancy, real-time RT-PCR was performed using the Applied Biosystems StepOnePlus System (Applied Biosystems, Foster City, CA, USA) using the SYBR Green method. Complementary DNAs were synthesized from 4 μg of total RNA isolated from different uterine endometrial tissues, and newly synthesized cDNAs (total volume of 21 μl) were diluted 1:4 with sterile water and then used for PCR. Specific primers based on porcine *MUC5AC* (GenBank accession number U10281.1; forward, 5′- CCA TCA TTT ACG AAG AGA CCG ACC-3′; reverse, 5′- GCC AGG TTT CAC CCT TCA TTC T-3′), *NRIP1* (GenBank accession number BV726910.1; forward, 5′-TCA AAA CTC CCC TGA GTC CTC CTT TC-3′; reverse, 5′- ACG TCC TTG TCT TGT GTT TCT CGA CT-3′), *RBP7* (GenBank accession number NM_001145222.1; forward, 5′- GAG CAA AAT GGG GAT TCT TTT ACC A-3′; reverse, 5′- ACA CTT GGC CTT CAC AGA ACA TCT C-3′), *ADAMTS20* (GenBank accession number XM_003126621.1; forward, 5′- GTT GCT GAT GGT ACT CCT TGT GGA A-3′; reverse, 5′- CGA TAA CGC CAG GTA ATT GTC ATC T-3′), and porcine ribosomal protein L7 (*RPL7*), (GenBank accession number NM_001113217; forward, 5′-AAG CCA AGC ACT ATC ACA AGG AAT ACA-3′; reverse, 5′-TGC AAC ACC TTT CTG ACC TTT GG-3′) were designed to amplify cDNAs of 216 bp, 250 bp, 250 bp, 285 bp, and 172 bp, respectively. The Power SYBR Green PCR Master Mix (Applied Biosystems) was used for PCR reactions. Final reaction volume was 20 μl including 2 μl of cDNA, 10 μl of 2X Master mix, 2 μl of each primer, and 4 μl of dH~2~O. PCR conditions were 95°C for 15 min followed by 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s. The results are reported as the expression relative to the level detected on D12 of the estrous cycle after normalization of the transcript amount to the endogenous *RPL7* control by the 2^−∆∆CT^ method ([@b35-ajas-25-8-1102-7]).

Statistic analysis
------------------

Data from real-time RT-PCR analysis for comparison of expression levels of selected genes in endometrium on D12 and D15 of the estrous cycle and pregnancy were subjected to the Student's *t* test procedure of SAS, and are presented as means with standard errors.

RESULTS
=======

Comparison of gene expression in the uterine endometrium between D12 and D15 of pregnancy and D12 and D15 of the estrous cycle
------------------------------------------------------------------------------------------------------------------------------

To determine global gene expression profiles in the uterine endometrium on D12 and D15 of the estrous cycle and of pregnancy in pigs, microarray analyses were performed using a total of 12 Affymetrix porcine genome microarray chips. To understand pregnancy-specific changes in endometrial gene expression, we identified differentially expressed genes with at least a two-fold increase or decrease in the uterine endometrium between D12 of pregnancy and D12 of the estrous cycle, as well as those with at least a two-fold increase or decrease between D15 of pregnancy and D15 of the estrous cycle.

After analyzing the raw data using the MAS5 algorithm of the GeneChip Operating Software, differentially expressed genes among the compared pairs were obtained. We considered genes that were below a Detection p-value of 0.05 and a two-fold change to be differentially expressed genes. Among 23,937 genes, 99 and 213 genes were up-regulated in the uterine endometrium on D12 and D15 of pregnancy compared to D12 and D15 of the estrous cycle, respectively. In addition, 92 and 231 genes were down-regulated in the endometrium on D12 and D15 of pregnancy compared to D12 and D15 of the estrous cycle, respectively. Volcano plot images showing comparative analyses of endometrial gene expression between the estrous cycle and pregnancy are shown in [Figure 1](#f1-ajas-25-8-1102-7){ref-type="fig"}.

Genes differentially expressed on D12 of pregnancy compared to those of D12 of the estrous cycle
------------------------------------------------------------------------------------------------

Genes that had higher expression in the uterine endometrium on D12 of pregnancy compared to those of D12 of the estrous cycle included sulfotransferase family 1E (*SULT1E1*), *LPAR3*, caspase 3 (*CASP3*), interleukin 1 receptor accessory protein (*IL1RAP*), and fibroblast growth factor 7 (*FGF7*) ([Supplementary Table 1](#SD1-ajas-25-8-1102-7){ref-type="supplementary-material"}). Genes that had lower expression in the endometrium on D12 of pregnancy compared to those of D12 of the estrous cycle included glutathione S-transferase (*GST*), mucin (*MUC5AC*), solute carrier family 2 (*SLC2A2*), cytochrome P450 3A46 (*CYP3A46*), keratin 7 (*KRT7*), chemokine ligand 12 (*CXCL12*), and interferon regulatory factor 7 (*IRF7*) ([Supplementary Table 2](#SD2-ajas-25-8-1102-7){ref-type="supplementary-material"}).

Genes differentially expressed on D15 of pregnancy compared to those of D15 of the estrous cycle
------------------------------------------------------------------------------------------------

Genes that had higher expression in the uterine endometrium on D15 of pregnancy compared to those of D15 of the estrous cycle included endoplasmic reticulum degradation enhancer mannosidase alpha-like 3 (*EDEM3*), neurotrimin (*NTM*), UDP-glucose ceramide glucosyltransferase (*UCGC*), nuclear receptor interacting protein 1 (*NRIP1*), and SMAD family member 2 (*SMAD2*) ([Supplementary Table 3](#SD3-ajas-25-8-1102-7){ref-type="supplementary-material"}). Genes that had lower expression in the endometrium on D15 of pregnancy compared to those of D15 of the estrous cycle included cellular retinol binding protein 7 (*RBP7*), parathyroid hormone (*PTH*), and myosin VI (*MYO6*) ([Supplementary Table 4](#SD4-ajas-25-8-1102-7){ref-type="supplementary-material"}).

Functional annotation clustering analysis
-----------------------------------------

To identify putative biological functions regulated by pregnancy in the uterine endometrium, we performed functional annotation clustering analysis of differentially expressed genes by the DAVID program. As a result, we obtained enriched functional groups in each cluster and clarified gene ontology (GO) terms or biological features of DEGs in the uterine endometrium ([Figure 2](#f2-ajas-25-8-1102-7){ref-type="fig"}). In genes up-regulated in the uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle, functional annotation clustering analysis showed that functional groups of membrane fraction and endoplasmic reticulum were enriched biological feature ([Supplementary Table 5](#SD5-ajas-25-8-1102-7){ref-type="supplementary-material"}). Biological functions of cell adhesion and immune cell activation were enriched in genes down-regulated in uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle ([Supplementary Table 6](#SD6-ajas-25-8-1102-7){ref-type="supplementary-material"}). RNA splicing and mRNA metabolism were enriched in genes up-regulated in the uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle ([Supplementary Table 7](#SD7-ajas-25-8-1102-7){ref-type="supplementary-material"}), whereas cytoskeloton, microtubule, actin dynein related functions were enriched in genes down-regulated in the uterine endometrium on D15 of pregnancy compared to those on D15 of the estrous cycle ([Supplementary Table 8](#SD8-ajas-25-8-1102-7){ref-type="supplementary-material"}).

Real-time RT-PCR analysis of *ADAMTS20*, *MUC5AC*, *NRIP1*, and *RBP7* in the uterine endometria on D12 and D15 of the estrous cycle and pregnancy
--------------------------------------------------------------------------------------------------------------------------------------------------

To determine validity of our microanalysis data, we selected *ADAMTS20*, *MUC5AC*, *NRIP1*, and *RBP7* from genes up-regulated or down-regulated in comparison groups between D12 and D15 of the estrous cycle and pregnancy, and analyzed expression levels of those genes using realtime RT-PCR analysis. Levels of *ADAMTS20* expression were significantly higher in the uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle (p\<0.05). Expression levels of *MUC5AC* were significantly lower in the uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle (p\<0.05). Levels of *NRIP1* expression was significantly higher in the uterine endometrium on D15 of the pregnancy compared with those on D15 of the estrous cycle (p\<0.05). However, levels of *RBP7* expression were not different in the uterine endometrium between D15 of the estrous cycle and pregnancy (p\>0.05).

DISCUSSION
==========

The establishment of pregnancy is a complex process that requires well-coordinated interactions between the maternal uterus and the developing conceptus. In pigs, the implantation process begins around D12 of pregnancy and completes around D18 ([@b16-ajas-25-8-1102-7]). During this period, the presence of the conceptus in the uterus induces changes in endometrial gene expression in preparation for conceptus attachment to the endometrial epithelial cells and extension of the life span of the corpus luteum in the ovaries ([@b48-ajas-25-8-1102-7]). To better understand the implantation process, this study aimed to identify changes in endometrial gene expression on D12 and D15 of pregnancy in comparison to expression on D12 and D15 of the estrous cycle using a microarray technique. In this study, we identified genes that were up-regulated or down-regulated in the uterine endometrium during the implantation period. These genes that were differentially expressed according to pregnancy status included genes involved in immunity, steroidogenesis, cell-to-cell interaction, and tissue remodeling. Furthermore, functional annotation functional clustering analysis of these genes showed that biological functions of cell-to-cell interaction and immune cell activation were decreased in the uterine endometrium on D12 of pregnancy compared to those on D12 of the estrous cycle and RNA processing was increased in the uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle.

On around D12 of pregnancy in pigs, maternal recognition of pregnancy occurs through a mechanism explained by the endocrine-exocrine theory ([@b2-ajas-25-8-1102-7]). The elongating conceptus secretes estrogen into the uterine lumen, which, in turn, acts on the uterine endometrium and redirects the secretion of PGF~2α~ toward the uterine lumen (exocrine) so that the corpus luteum (CL) function is maintained in the ovary. On the other hand, the absence of a conceptus in cyclic pigs on D12 causes secretion of PGF~2α~ into the uterine vasculature (endocrine), which exerts luteolytic action on the CL. Thus, it is likely that the expression of endometrial genes on D12 of pregnancy is affected by the action of the estrogen originating from the conceptus. Indeed, it has been shown that the expressions of *FGF7* and *LPAR3* are up-regulated following estrogen treatment in uterine endometrium ([@b23-ajas-25-8-1102-7]; [@b47-ajas-25-8-1102-7]). In addition to estrogen, the conceptus also produces cytokines such as IL-1β, IFN-γ and IFN-δ ([@b48-ajas-25-8-1102-7]), and the uterine environment during this period is also influenced by progesterone of ovarian origin. Therefore, expression of endometrial genes on D12 of pregnancy would be affected by a coordinated interaction of these factors.

Genes up-regulated in the endometrium of pregnant pigs on D12 of pregnancy compared to genes of D12 of the estrous cycle include *SULT1E1, LPAR3, IL1RAP*, and *FGF7*. Previous studies in pigs have demonstrated that these genes are expressed in the endometrium at significantly higher levels on D12 of pregnancy than on D12 of the estrous cycle ([@b26-ajas-25-8-1102-7]; [@b29-ajas-25-8-1102-7]; [@b45-ajas-25-8-1102-7]; [@b47-ajas-25-8-1102-7]), indicating the validity of our microarray approach in analyzing gene expression. In addition, many other genes, including *ADAMTS17, ADAMTS20, CASP3, CCNA2*, and *CYP19*, were also identified as being up-regulated in the endometrium of pregnant pigs on D12 of pregnancy compared with genes on D12 of the estrous cycle. In functional annotation clustering analysis using genes up-regulated in the uterine endometrium on D12 of pregnancy compared with genes on D12 of the estrous cycle, any notable biological function was not found due to low relatedness of biological terms and low numbers of genes having similar function.

Down-regulated genes in the endometrium of pigs on D12 of pregnancy compared with genes on D12 of the estrous cycle include genes representing biological functions of leukocyte activation (*CD86, CD8A, CXCL12, KLRK1, MLL5, PTPN22*, and *UNC13D*), cell adhesion (*AJAP1, CNTN5, CXCL12, CYFIP2, EGFL6, FAT1, ITGB4, ITGB7, MUC5AC, PKP2*, and *ROBO1*), and cell junction (*AJAP1, CYFIP2, GABRA5, GRIP1, PKP2, SHROOM2*, and *TNS3*). During the implantation period in pigs, immune cell population changes and effector T cell population decreases in the subepithelial regions of the uterine endometrium ([@b9-ajas-25-8-1102-7]; [@b5-ajas-25-8-1102-7]; [@b27-ajas-25-8-1102-7]), suggesting that maternal immune suppression contributes to the establishment of pregnancy. CD86, together with CD80, regulates T cell function as a ligand for CD28 and cytotoxic lymphocyte antigen-4 (CTLA-4), and expression of CD86 is detected in macrophages and dendritic cells at the feto-maternal interface in human ([@b1-ajas-25-8-1102-7]) and mouse ([@b43-ajas-25-8-1102-7]). Interestingly, decreased expression of CD86 in the uterine endometrium with the conceptus on D12 of pregnancy compared D12 of the estrous cycle indicate that regulation of maternal uterine T cell function may also be important for the establishment of pregnancy in pigs. CXCL12 plays a key role in lymphocyte trafficking, cellular proliferation, organogenesis, vascularization, and embryogenesis ([@b39-ajas-25-8-1102-7]; [@b58-ajas-25-8-1102-7]). CXCL12 has been shown to be expressed in the uterine endometrium of humans and bovines ([@b22-ajas-25-8-1102-7]; [@b36-ajas-25-8-1102-7]). In human trophoblasts and decidual cells, CXCL12 increases the invasiveness of trophoblasts and matrix metalloproteinase (MMP) 9 and MMP2 activity ([@b59-ajas-25-8-1102-7]) and has also been shown to be associated with endovascular invasion of CD16-NK cells in human placenta ([@b22-ajas-25-8-1102-7]). In this study, expression of CXCL12 decreased in pregnant uterine endometrium. Although its function in the uterine endometrium needs to be further elucidated during early pregnancy in pigs, modulation of CXCL12 action may also be important for embryo implantation.

During the implantation period in rodents, humans, and ruminants, it has been shown that expression of MUC1, a type of transmembrane mucin, is decreased in uterine endometrial epithelial cells to allow for adhesion of the conceptus trophectoderm to endometrial epithelial cells ([@b7-ajas-25-8-1102-7]; [@b49-ajas-25-8-1102-7]). MUC5AC is a secreted, large, gel-forming type of mucin ([@b17-ajas-25-8-1102-7]). Its expression has been measured in human uterine endocervical epithelial cells as a major form of gel-forming mucin in the menstrual cycle ([@b18-ajas-25-8-1102-7]), and it is associated with a change in eosinophilic cells in endometrial carcinomas ([@b38-ajas-25-8-1102-7]). Decreased expression of *MUC5AC* in pregnant uterine endometrium suggests that MUC5AC, in addition to MUC1, may block adhesion of the conceptus trophectoderm and must be removed for the trophectoderm to undergo epithelial cell attachment.

We also compared the genes expressed in the endometrium on D15 of pregnancy to those expressed on D15 of the estrous cycle. On D15 of the estrous cycle, the period of late diestrus in pigs, luteolysis is initiated by extended exposure of the endometrium to progesterone for 10 to 12 d, followed by increased pulsatile production of PGF~2α~ ([@b60-ajas-25-8-1102-7]). According to a study in sheep, the initial exposure to progesterone down-regulates the endometrial epithelial expressions of ESR1 and PGR, and the loss of the action of progesterone permits estrogen to increase ESR1 and OXTR in the uterine endometrium ([@b48-ajas-25-8-1102-7]). Pulsatile release of oxytocin induces subluteolytic pulses of PGF~2α~ from the uterine endometrium. PGF~2α~ causes a supplemental release of oxytocin from the CL, which in turn stimulates the secretion of a luteolytic pulse of PGF~2α~ from the uterine endometrium through a positive feedback mechanism. This positive feedback loop continues until the CL is depleted of oxytocin ([@b48-ajas-25-8-1102-7]). On the other hand, on D15 of pregnancy, maternal recognition of pregnancy is established, and interdigitation between the chorion and endometrial epithelial cells develops to form the epitheliochorial placenta ([@b10-ajas-25-8-1102-7]). During this time, the uterine environment is under the influence of progesterone, which is continuously produced from the ovaries, and cytokines originating from the conceptus, such as IFN-γ and IFN-δ ([@b8-ajas-25-8-1102-7]). It has been shown that a large amount of IFN-γ is secreted by the pig conceptus between d 12 and 20 of pregnancy (up to 250 mg per uterine horn), with the highest levels of synthesis on D15 and D16 ([@b30-ajas-25-8-1102-7]). At this time, ESR1 expression is decreased in the endometrium, and PGR is only detectable in stromal cells ([@b14-ajas-25-8-1102-7]; [@b15-ajas-25-8-1102-7]).

In this study, many novel genes whose roles in the uterus have not been fully studied were identified as being differentially expressed in the endometrium between D15 of pregnancy and D15 of the estrous cycle. Among genes that were up-regulated in the endometrium on D15 of pregnancy compared to those on D15 of the estrous cycle *were AKAP1, AKAP11, AKAP13, CLCN3, EDEM3, NRIP1*, and *SMAD2;* down-regulated genes in the endometrium on D15 of pregnancy compared to those on D15 of the estrous cycle included *ATP2C2, EFHA2, FOXN3, MYO6, PER1, PTH* and *RBP7*. NRIP1, formerly known as receptor interacting protein 140 (RIP140), is a widely expressed corepressor that has the potential to inhibit the transcriptional activities of most nuclear receptors, including ESR1, PGR, and GR. Studies have shown that NRIP1 is expressed in metabolic tissues and plays a critical role in lipid metabolism ([@b11-ajas-25-8-1102-7]). The importance of NRIP1 in reproduction has been shown in a study of *Nrip1*-null mice ([@b56-ajas-25-8-1102-7]), which are viable, but whose females are infertile due to a failure to release mature oocytes ([@b56-ajas-25-8-1102-7]). The expression and function of NRIP1 in reproductive tissues have not been heavily studied, but some data in mice and rats have shown that *Nrip1* is expressed in the uterus ([@b40-ajas-25-8-1102-7]; [@b33-ajas-25-8-1102-7]). In mice, *Nrip1* expression is localized to glandular epithelial cells, stromal cells, and decidual cells, but is not observed in luminal epithelial cells in the uterine endometrium ([@b33-ajas-25-8-1102-7]). In women, mutation of the *NRIP1* gene is associated with endometriosis, suggesting that mutation of this gene may be a predisposing factor for endometriosis ([@b6-ajas-25-8-1102-7]). There is no information available on the expression and function of NRIP1 in the porcine uterus. However, NRIP1 may play an important role in regulating lipid hormonal actions for the establishment of pregnancy, because the uterus is continuously influenced by steroid hormones (mainly estrogen and progesterone) during early pregnancy. Further characterization of the mechanism of NRIP1 action in the uterus during early pregnancy is needed.

SMAD2 is one of the key modulators in the TGF-β signaling pathway. When the TGF receptor is activated by TGF-β binding, SMAD2 binds to the TGF-β-receptor complex and is activated by C-terminal phosphorylation. Phosphorylated SMAD2 pairs with SMAD4 and relocates to the nucleus, where it acts as a transcription factor to induce target gene expression (ten [@b50-ajas-25-8-1102-7]). In rodents, SMAD2 expression in the uterus has been well characterized. During the estrous cycle, *Smad2* expression is localized to luminal and glandular epithelial cells, but its expression is predominantly localized to the subluminal stroma surrounding the implanting embryo during the peri-implantation period ([@b34-ajas-25-8-1102-7]). In the porcine uterus, phosphorylated SMAD2/3 was localized to endometrial luminal and glandular epithelilal cells, stromal cells, and endothelial cells (as well as the conceptus trophectoderm) on D13 of pregnancy, and activation of SMAD2/3 in endometrial luminal epithelial cells by TGF-β infusion into the uterine lumen has been demonstrated ([@b37-ajas-25-8-1102-7]). In pigs, it has been suggested that TGF-β, which is present at the maternal-fetal interface during the implantation period ([@b21-ajas-25-8-1102-7]), acts in trophectodermal cell-to-luminal epithelial cell adhesion ([@b37-ajas-25-8-1102-7]). Thus, increased expression of SMAD2 in the endometrium of pregnant pigs on D15 may indicate that TGF-β signaling is activated in conceptus implantation.

Recently, microarray analysis has been applied in determining DEGs in the uterine endometrium in pregnant pigs compared with genes expressed in non-pregnant pigs, showing that DEGs are involved in gene function of developmental process, transporter activity, calcium ion binding, apoptosis, cell motility, enzyme-linked protein receptor signaling pathway, positive regulation of cell proliferation, ion homeostasis, and hormone activity ([@b41-ajas-25-8-1102-7]). Microarray analysis has also been applied to determine the pattern of global gene expression during the implantation period in several species, including humans ([@b28-ajas-25-8-1102-7]), mice ([@b42-ajas-25-8-1102-7]), bovine ([@b53-ajas-25-8-1102-7]), and ovine ([@b46-ajas-25-8-1102-7]). A direct comparison of genes expressed in the uterine endometrium during the implantation period in pigs to genes in other species is not possible because of varying experimental settings between studies and limited information on annotated genes in the porcine genome. However, it seems that very few genes expressed in the porcine uterine endometrium match the genes expressed in other species, which may result from different mechanisms of implantation and placentation in pigs.

The data presented in this study provides information on the genes expressed in the uterine endometrium during the implantation period in pigs. Expression of a gene during this period does not necessarily mean that the gene is critical for conceptus implantation; as such, further functional characterization of those genes is essential. Nevertheless, data from this study will provide insight into the mechanism of the implantation process for the establishment of pregnancy in pigs. In addition, the experimental setting used in this study may be applicable to the screening of candidate genes related to prolificacy among pig breeds and to low implantation rates in the production of somatic cell nuclear transfer cloned pigs.
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List of top 30 genes up-regulated in the uterine endometrium on day (D) 12 of pregnancy compared to genes on D12 of the estrous cycle by average fold change

  Probe set ID          Average log_2(Fold change)   Gene symbol   Gene title                                                                                 RefSeq transcript ID
  --------------------- ---------------------------- ------------- ------------------------------------------------------------------------------------------ ----------------------
  Ssc.12.1.S1_at        5.1138                       *SULT1E1*     Sulfotransferase family 1E, estrogen-preferring, member 1                                  NM_213992
  Ssc.31161.1.A1_at     4.2407                       *ADAMTS20*    ADAM metallopeptidase with thrombospondin type 1 motif, 20                                 NM_025003
  Ssc.7637.1.A1_at      4.0102                       *LIMCH1*      LIM and calponin homology domains 1                                                        NM_001112717
  Ssc.17508.2.A1_at     3.9781                       *RCAN2*       Regulator of calcineurin 2                                                                 NM_005822
  Ssc.3102.2.A1_at      3.8907                       *LPAR3*       Lysophosphatidic acid receptor 3                                                           NM_012152
  Ssc.3102.1.S1_at      3.8637                       *LPAR3*       Lysophosphatidic acid receptor 3                                                           NM_001162402
  Ssc.9019.1.A1_at      3.8489                       *NPR3*        Natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)   NM_000908
  Ssc.7890.1.S1_at      3.3443                       *C5orf23*     Chromosome 5 open reading frame 23                                                         NM_024563
  Ssc.27625.1.S1_at     2.9314                       *GJB5*        Gap junction protein, beta 5, 31.1kDa                                                      NM_005268
  Ssc.14085.1.A1_at     2.8601                       *LRRTM3*      Leucine rich repeat transmembrane neuronal 3                                               NM_178011
  Ssc.18819.1.A1_at     2.8266                       *SYT13*       Synaptotagmin XIII                                                                         NM_020826
  Ssc.29244.1.A1_at     2.6149                       *SORCS3*      Sortilin-related VPS10 domain containing receptor 3                                        NM_014978
  Ssc.12902.1.A1_at     2.3709                       *SLC22A2*     Solute carrier family 22 (organic cation transporter), member 2                            NM_003058
  Ssc.21585.2.S1_at     2.3324                       *UBR7*        Ubiquitin protein ligase E3 component n-recognin 7 (putative)                              NM_001100417
  Ssc.12523.1.A1_at     2.3272                       *CLIC4*       Chloride intracellular channel 4                                                           NM_013943
  Ssc.15886.1.S1_at     2.3001                       *CASP3*       Caspase 3, apoptosis-related cysteine peptidase                                            NM_214131
  Ssc.7864.1.A1_at      2.1904                       *IL1RAP*      Interleukin 1 receptor accessory protein                                                   NM_002182
  Ssc.18027.1.S1_at     2.1855                       *BTBD3*       BTB (POZ) domain containing 3                                                              NM_014962
  Ssc.6441.2.S1_at      2.1576                       *DHRS7*       Dehydrogenase/reductase (SDR family) member 7                                              NM_016029
  Ssc.8552.3.S1_a\_at   2.1220                       *GGTA1*       Glycoprotein, alpha-galactosyltransferase 1                                                NM_213810
  Ssc.21460.1.A1_at     1.9430                       *CREG1*       Cellular repressor of E1A-stimulated genes 1                                               NM_003851
  Ssc.13221.1.A1_at     1.8729                       *PC*          Pyruvate carboxylase                                                                       NM_000920
  Ssc.4999.1.S1_at      1.8630                       *AVPI1*       Arginine vasopressin-induced 1                                                             NM_021732
  Ssc.14304.1.A1_at     1.8514                       *CLSTN2*      Calsyntenin 2                                                                              NM_022131
  Ssc.15923.1.A1_at     1.8044                       *FGF7*        Fibroblast growth factor 7                                                                 AF217463.1
  Ssc.30862.1.S1_at     1.8001                       *DNAJB9*      DnaJ (Hsp40) homolog, subfamily B, member 9                                                NM_012328
  Ssc.31013.2.S1_at     1.7794                       *KCTD3*       Potassium channel tetramerisation domain containing 3                                      NM_016121
  Ssc.12056.1.A1_at     1.7746                       *LOXL4*       Lysyl oxidase-like 4                                                                       NM_032211
  Ssc.24450.1.S1_at     1.7716                       *F13B*        Coagulation factor XIII, B polypeptide                                                     NM_001994
  Ssc.12412.1.A1_at     1.7315                       *SDF2L1*      Stromal cell-derived factor 2-like 1                                                       NM_022044

###### 

List of top 30 genes down-regulated in the uterine endometrium on day (D) 12 of pregnancy compared to genes on D12 of the estrous cycle by average fold change

  Probe set ID           Average log_2(Fold change)   Gene symbol   Gene title                                                               RefSeq transcript ID
  ---------------------- ---------------------------- ------------- ------------------------------------------------------------------------ ----------------------
  Ssc.10837.1.A1_at      −3.994277                    *ROBO1*       Roundabout, axon guidance receptor, homolog 1 (Drosophila)               NM_002941
  Ssc.15850.1.S1_a\_at   −3.892519                    *TRA@*        T cell receptor alpha locus                                              NW_001838110.1
  Ssc.16377.2.A1_at      −3.697358                    *GSTA3*       Glutathione S-transferase alpha 3                                        NM_000847
  Ssc.3904.1.S1_at       −2.781738                    *RPS6KA6*     Ribosomal protein S6 kinase, 90kDa, polypeptide 6                        NM_014496
  Ssc.16767.1.S1_at      −2.76431                     *HNRNPL*      Heterogeneous nuclear ribonucleoprotein L-like                           NM_001005335
  Ssc.338.1.S1_at        −2.656394                    *MUC5AC*      Mucin 5AC, oligomeric mucus/gel-forming                                  NM_017511.1
  Ssc.22190.1.S1_at      −2.632552                    *AJAP1*       Adherens junctions associated protein 1                                  NM_001042478
  Ssc.8621.1.A1_at       −2.490124                    *PRKACB*      Protein kinase, cAMP-dependent, catalytic, Beta                          NM_002731
  Ssc.23849.1.A1_at      −2.457561                    *SLC2A2*      Solute carrier family 2 (facilitated glucose transporter), member 2      NM_000340
  Ssc.25254.1.S1_at      −2.378661                    *RHOJ*        Ras homolog gene family, member J                                        NM_020663
  Ssc.21224.1.A1_at      −2.352619                    *KRT7*        Keratin 7                                                                NM_005556
  Ssc.6556.2.A1_at       −2.344349                    *GABRA5*      Gamma-aminobutyric acid (GABA) A receptor, alpha 5                       NM_000810
  Ssc.27912.1.S1_at      −2.205287                    *ZNF608*      Zinc finger protein 608                                                  NM_020747
  Ssc.24434.1.S1_at      −2.16435                     *C14orf145*   Chromosome 14 open reading frame 145                                     NM_152446.3
  Ssc.26326.1.A1_at      −2.134067                    *CYP3A46*     Cytochrome P450 3A46                                                     NM_001134824
  Ssc.11260.1.A1_at      −2.124412                    *GSTA1*       Glutathione S-transferase alpha 1                                        NM_145740
  Ssc.8053.1.S1_at       −1.953481                    *POLL*        Polymerase (DNA directed), lambda                                        NM_013274
  Ssc.2618.1.S1_at       −1.827725                    *MAMDC4*      MAM domain containing 4                                                  NM_206920
  Ssc.5641.1.S1_at       −1.80541                     *ANK2*        Ankyrin 2, neuronal                                                      NM_001127493
  Ssc.18992.1.A1_at      −1.784956                    *ANKRD6*      Ankyrin repeat domain 6                                                  NM_014942
  Ssc.30445.1.A1_at      −1.761477                    *ALK*         Anaplastic lymphoma receptor tyrosine Kinase                             NM_004304
  Ssc.27318.1.S1_at      −1.757688                    *KRT7*        Keratin 7                                                                NM_005556
  Ssc.30532.1.A1_at      −1.725776                    *XRCC2*       X-ray repair complementing defective repair in Chinese hamster cells 2   NM_005431
  Ssc.27626.1.S1_at      −1.719731                    *EGFL6*       EGF-like-domain, multiple 6                                              NM_015507
  Ssc.12223.1.A1_at      −1.690582                    *PTPN22*      Protein tyrosine phosphatase, non-receptor type 22 (lymphoid)            NM_012411
  Ssc.336.1.S1_at        −1.631299                    *USP18*       Ubiquitin specific peptidase 18                                          NM_213826
  Ssc.15708.1.S1_at      −1.621459                    *HBZ*         Hemoglobin, zeta                                                         NM_005332
  Ssc.7243.1.A1_at       −1.619644                    *CXCL12*      Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)        NM_001009580
  Ssc.21162.1.S1_s\_at   −1.609334                    *IRF7*        Interferon regulatory factor 7                                           NM_001097428
  Ssc.286.1.S1_s\_at     −1.553267                    *IRG6*        Inflammatory response protein 6                                          NM_213817

###### 

List of top 30 genes up-regulated in the uterine endometrium on day (D) 15 of pregnancy compared to genes on D15 of the estrous cycle by average fold change

  Probe set ID         Average log_2(Fold change)   Gene symbol         Gene title                                                                    RefSeq transcript ID
  -------------------- ---------------------------- ------------------- ----------------------------------------------------------------------------- ----------------------
  Ssc.28494.1.S1_at    3.9383217                    *RAB5B*             RAB5B, member RAS oncogene family                                             NM_002868
  Ssc.18273.1.A1_at    3.9374428                    *MAGI1*             Membrane associated guanylate kinase, WW and PDZ domain containing 1          NM_173515
  Ssc.22734.1.A1_at    3.505833                     *EDEM3*             ER degradation enhancer, mannosidase alpha- like 3                            NM_025191
  Ssc.6392.1.S1_at     3.3603669                    *NTM*               Neurotrimin                                                                   NM_001144058.1
  Ssc.25740.1.A1_at    3.3474057                    *AKAP1*             A kinase (PRKA) anchor protein 1                                              NM_003488
  Ssc.9329.1.A1_at     3.0693123                    *PTPLAD2*           Protein tyrosine phosphatase-like A domain containing 2                       NM_001010915
  Ssc.10593.2.A1_at    3.0355328                    *IFI44L*            Interferon-induced protein 44-like                                            NM_006820
  Ssc.11925.1.A1_at    2.8589389                    *SEL1L*             Sel-1 suppressor of lin-12-like (C. Elegans)                                  NM_005065
  Ssc.25678.1.S1_at    2.8213114                    *SYT1*              Synaptotagmin I                                                               NM_005639
  Ssc.12809.5.A1_at    2.7832047                    *HBA2*              Hemoglobin, alpha 2; hemoglobin, alpha 1                                      NM_000517
  Ssc.7455.1.A1_at     2.7595911                    *AASDHPPT*          Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase       NM_015423
  Ssc.7682.1.A1_at     2.6842858                    *OSBPL9*            Oxysterol binding protein-like 9                                              NM_024586
  AFFX-Ss_18SrRNA_at   2.6236143                    *AFFX-Ss_18SrRNA*   AFFX-Ss_18SrRNA                                                               Null
  Ssc.21585.2.S1_at    2.5961034                    *UBR7*              Ubiquitin protein ligase E3 component n-recognin 7 (putative)                 NM_001100417
  Ssc.13473.1.A1_at    2.5538991                    *UGCG*              UDP-glucose ceramide glucosyltransferase                                      NM_003358
  Ssc.27407.1.A1_at    2.5424531                    *NRIP1*             Nuclear receptor interacting protein 1                                        NM_003489
  Ssc.3975.2.A1_at     2.4775446                    *STK38L*            Serine/threonine kinase 38 like                                               NM_015000.3
  Ssc.28192.1.A1_at    2.4555041                    *FAM153A*           Family with sequence similarity 153, member A                                 NM_173663
  Ssc.20353.1.S1_at    2.3855645                    *MALT1*             Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)   NR_002819.2
  Ssc.11870.1.A1_at    2.2433352                    *NRIP1*             Nuclear receptor interacting protein 1                                        NM_003489
  Ssc.17508.2.A1_at    2.2266604                    *RCAN2*             Regulator of calcineurin 2                                                    NM_005822
  Ssc.8143.2.A1_at     2.1943771                    *RAPGEF2*           Rap guanine nucleotide exchange factor (GEF) 2                                NM_014247
  Ssc.17152.2.A1_at    2.1849978                    *COQ2*              Coenzyme Q2 homolog, prenyltransferase (Yeast)                                NM_015697
  Ssc.27130.1.A1_at    2.1615496                    *SLC25A36*          Solute carrier family 25, member 36                                           NM_001104647
  Ssc.3325.3.S1_at     2.1184436                    *EXT1*              Exostoses (multiple) 1                                                        NM_000127
  Ssc.22645.1.S1_at    2.0685056                    *DDX46*             DEAD (Asp-Glu-Ala-Asp) box polypeptide 46                                     NM_014829
  Ssc.6175.1.S1_at     2.0623846                    *LCOR*              Ligand dependent nuclear receptor corepressor                                 NM_032440
  Ssc.13601.1.A1_at    1.8954884                    *MYO1B*             Myosin IB                                                                     NM_001130158
  Ssc.24402.1.S1_at    1.8920959                    *CCDC76*            Coiled-coil domain containing 76                                              NM_019083
  Ssc.27133.1.A1_at    1.8789606                    *TMEM68*            Transmembrane protein 68                                                      NM_152417
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List of top 30 genes down-regulated in the uterine endometrium on day (D) 15 of pregnancy compared to genes on D15 of the estrous cycle by average fold change

  Probe set ID          Average log_2(Fold change)   Gene symbol   Gene title                                                                   RefSeq transcript ID
  --------------------- ---------------------------- ------------- ---------------------------------------------------------------------------- ----------------------
  Ssc.25087.1.S1_at     −4.665941                    *DNAJC13*     DnaJ (Hsp40) homolog, subfamily C, member 13                                 NM_015268
  Ssc.2015.2.S1_at      −4.469763                    *ZNF449*      Zinc finger protein 449                                                      NM_152695
  Ssc.7817.1.A1_at      −4.302148                    *NETO1*       Neuropilin (NRP) and tolloid (TLL)-like 1                                    NM_138966
  Ssc.23424.1.A1_at     −4.072875                    *DTNA*        Dystrobrevin, alpha                                                          NM_001128175
  Ssc.8989.1.A1_at      −3.882042                    *PPHLN1*      Periphilin 1                                                                 NM_016488
  Ssc.21088.2.S1_at     −3.009555                    *CSTF1*       Cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50kDa                    NM_001033521
  Ssc.9834.2.S1_at      −2.875995                    *Null*        Sn36_F05.f sn Sus scrofa cDNA                                                CB471302.1
  Ssc.1600.1.A1_at      −2.684489                    *RIMKLB*      Ribosomal modification protein rimK-like family member B                     NM_020734.2
  Ssc.1600.1.A1_a\_at   −2.616954                    *RIMKLB*      Ribosomal modification protein rimK-like family member B                     NM_020734.2
  Ssc.27385.1.S1_at     −2.580643                    *RBP7*        Retinol binding protein 7, cellular                                          NM_001145222
  Ssc.668.1.S1_at       −2.543521                    *PTH*         Parathyroid hormone                                                          NM_214401
  Ssc.958.1.S1_at       −2.543376                    *ALDOB*       Aldolase B, fructose-bisphosphate                                            NM_000035
  Ssc.27953.1.S1_at     −2.289442                    *MLL*         Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)   NM_005933
  Ssc.21468.2.A1_at     −2.194019                    *LARP1*       La ribonucleoprotein domain family, member 1                                 NM_015315
  Ssc.30456.1.A1_at     −2.155805                    *CCDC135*     Coiled-coil domain containing 135                                            NM_032269
  Ssc.27345.1.S1_at     −2.107692                    *Null*        940760 MARC 4PIG Sus scrofa cDNA                                             CN153625.1
  Ssc.7219.1.A1_at      −1.926105                    *ERC2*        ELKS/RAB6-interacting/CAST family member 2                                   NM_015576
  Ssc.22791.1.A1_at     −1.922899                    *EEA1*        Early endosome antigen 1                                                     NM_003566
  Ssc.7672.1.A1_at      −1.847485                    *CAPZB*       Capping protein (actin filament) muscle Z-line, beta                         NM_004930
  Ssc.25130.1.A1_at     −1.83943                     *C6orf98*     Chromosome 6 open reading frame 98                                           NM_001099267
  Ssc.30379.1.A1_at     −1.831398                    *ARMC3*       Armadillo repeat containing 3                                                NM_173081
  Ssc.7191.1.A1_at      −1.805                       *LSM14A*      LSM14A, SCD6 homolog A (S. Cerevisiae)                                       NM_001114093
  Ssc.2589.1.S1_at      −1.790171                    *TNNI3*       Troponin I type 3 (cardiac)                                                  NM_001098599
  Ssc.23948.1.A1_at     −1.727051                    *DYNC1I2*     Dynein, cytoplasmic 1, intermediate chain 2                                  NM_001378
  Ssc.8133.1.A1_at      −1.725898                    *GPM6B*       Glycoprotein M6B                                                             NM_001001994
  Ssc.28842.1.A1_at     −1.685047                    *CCDC113*     Coiled-coil domain containing 113                                            NM_014157
  Ssc.7917.1.A1_at      −1.680845                    *Null*        MI-P-E6-ahn-e-09-1-UM.s1 MI-P-E6 Sus scrofa cDNA clone                       BQ599768.1
  Ssc.29910.1.A1_at     −1.633574                    *MTMR2*       Myotubularin related protein 2                                               NM_016156
  Ssc.6616.1.S1_at      −1.629585                    *C1orf92*     Chromosome 1 open reading frame 92                                           NM_144702
  Ssc.28950.1.A1_at     −1.627009                    *EXOC6*       Exocyst complex component 6                                                  NM_019053.4

###### 

Functional annotation clusters of up-regulated genes in uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle

  Annotation cluster[a](#tfn1-ajas-25-8-1102-7){ref-type="table-fn"}   Enrichment score[b](#tfn2-ajas-25-8-1102-7){ref-type="table-fn"}   Biological terms[c](#tfn3-ajas-25-8-1102-7){ref-type="table-fn"}
  -------------------------------------------------------------------- ------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                                    2.56                                                               Membrane fraction (12), cell fraction (14), insoluble fraction (12)
  2                                                                    1.04                                                               Endoplasmic reticulum part (6), endoplasmic reticulum membrane (5), endoplasmic reticulum (10), nuclear envelope-endoplasmic reticulum network (5), microsome (4), vesicular fraction (4), organelle membrane (9), endomembrane system (6)
  3                                                                    0.88                                                               Blood vessel morphogenesis (4), blood vessel development (4), vasculature development (4)
  4                                                                    0.86                                                               Cellular macromolecule catabolic process (9), proteolysis (11), macromolecule catabolic process (9), proteolysis involved in cellular protein catabolic process (7), cellular protein catabolic process (7), protein catabolic process (7), ubiquitin- protein ligase activity (3), small conjugating protein ligase activity (3), ligase activity, forming carbon-nitrogen bonds (3), ubiquitin-dependent protein catabolic process (3), modification-dependent macromolecule catabolic process (6), acid- amino acid ligase activity (3), modification-dependent protein catabolic process (6)
  5                                                                    0.80                                                               Intracellular organelle lumen (14), organelle lumen (14), nuclear lumen (10), membrane-enclosed lumen (14), nucleoplasm (8)
  6                                                                    0.72                                                               Proteolysis (11), metalloendopeptidase activity (3), endopeptidase activity (5), negative regulation of apoptosis (5), negative regulation of programmed cell death(5), negative regulation of cell death (5), metallopeptidase activity (3), peptidase activity, acting on L-amino acid peptides (5), peptidase activity (5), regulation of apoptosis (6), regulation of programmed cell death (6), regulation of cell death (6)
  7                                                                    0.72                                                               Phosphatase activity (5), phosphoprotein phosphatase activity (4), phosphate metabolic process (9), dephosphorylation (4), phosphorus metabolic process (9), protein amino acid dephosphorylation (3), protein serine/threonine kinase activity(3), phosphorylation (5), protein amino acid phosphorylation (5), protein kinase activity (3)
  8                                                                    0.71                                                               Positive regulation of multicellular organismal process (4), positive regulation of cell proliferation (5), regulation of growth (4)
  9                                                                    0.65                                                               Cell cycle (8), mitotic cell cycle (5), cell cycle process (5), cell cycle phase (4)
  10                                                                   0.65                                                               Glycosaminoglycan binding (3), polysaccharide binding (3), pattern binding (3), carbohydrate binding (3)

Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D12 of pregnancy compared with those on D12 of the estrous cycle through DAVID.

Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.

The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.

###### 

Functional annotation clusters of down-regulated genes in uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle

  Annotation cluster[a](#tfn4-ajas-25-8-1102-7){ref-type="table-fn"}   Enrichment score[b](#tfn5-ajas-25-8-1102-7){ref-type="table-fn"}   Biological terms[c](#tfn6-ajas-25-8-1102-7){ref-type="table-fn"}
  -------------------------------------------------------------------- ------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                                    2.04                                                               Plasma membrane part (22), integral to plasma membrane (11), intrinsic to plasma membrane (11)
  2                                                                    2.03                                                               Cell adhesion (11), biological adhesion (11), cell-cell adhesion (4)
  3                                                                    1.50                                                               Leukocyte activation (7), cell activation (7), lymphocyte activation (6), T cell activation (4), immune effector process (4), regulation of leukocyte activation (4), regulation of cell activation (4), leukocyte mediated immunity (3), cell surface (5), positive regulation of response to stimulus (4), positive regulation of immune system process (4), immune response (7), external side of plasma membrane (3)
  4                                                                    1.48                                                               Immune system development (7), hemopoiesis (6), hemopoietic or lymphoid organ development (6), myeloid cell differentiation (3), protein homodimerization activity (4), nucleoplasm part (3)
  5                                                                    1.46                                                               Cell junction (7), adherens junction (4), anchoring junction 4)
  6                                                                    1.45                                                               Biopolymer glycosylation (4), glycoprotein biosynthetic process (4), glycoprotein metabolic process (4), glycosylation (4), protein amino acid glycosylation (4)
  7                                                                    0.98                                                               Apoptosis (7), programmed cell death (7), cell death (7), death (7), negative regulation of cell proliferation (4)
  8                                                                    0.83                                                               DNA metabolic process (8), response to DNA damage stimulus (5), DNA repair (4), cellular response to stress (5), DNA binding (7)
  9                                                                    0.83                                                               Induction of apoptosis (5), induction of programmed cell death (5), positive regulation of apoptosis (5), positive regulation of programmed cell death (5), positive regulation of cell death (5), regulation of apoptosis (7), regulation of programmed cell death (7), regulation of cell death (7)
  10                                                                   0.76                                                               Response to ionizing radiation (3), response to radiation (3), response to abiotic stimulus (3)

Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D15 of pregnancy compared with those on D15 of the estrous cycle.

Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.

The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.

###### 

Functional annotation clusters of up-regulated genes in uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle

  Annotation cluster[a](#tfn7-ajas-25-8-1102-7){ref-type="table-fn"}   Enrichment score[b](#tfn8-ajas-25-8-1102-7){ref-type="table-fn"}   Biological terms[c](#tfn9-ajas-25-8-1102-7){ref-type="table-fn"}
  -------------------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                                    3.46                                                               Nuclear speck (7), nuclear body (8), RNA splicing (9)
  2                                                                    2.21                                                               Nucleotide binding (30), purine ribonucleotide binding (25), AT P binding (21), ribonucleotide binding (25), purine nucleotide binding (25), adenyl ribonucleotide binding (21), adenyl nucleotide binding (21), purine nucleoside binding (21), nucleoside binding (21)
  3                                                                    2.12                                                               Nuclear body (8), nucleoplasm part (12), nucleoplasm (15), membrane-enclosed lumen (24), nuclear lumen (20), intracellular organelle lumen (23), organelle lumen (23), nucleolus (9)
  4                                                                    1.51                                                               RNA splicing (9), mrna metabolic process (9), RNA processing (11), mrna processing (8), spliceosome assembly (3), RNA splicing, via transesterification reactions (5), RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (5), nuclear mrna splicing, via spliceosome (5), RNA binding (11), ribonucleoprotein complex assembly (3), ribonucleoprotein complex biogenesis (4), cellular macromolecular complex assembly (5), cellular macromolecular complex subunit organization (5)
  5                                                                    1.15                                                               Nuclear body (8), nuclear export (4), nucleocytoplasmic transport (4), nuclear transport (4), mrna transport (3), establishment of RNA localization (3), nucleic acid transport (3), RNA transport (3), RNA localization (3), nucleobase, nucleoside, nucleotide and nucleic acid transport (3), intracellular transport (8)
  6                                                                    1.06                                                               Receptor-mediated endocytosis (4), membrane organization (8), membrane invagination (4), endocytosis (4), vesicle-mediated transport (6)
  7                                                                    0.96                                                               Helicase activity (6), ATP-dependent helicase activity (3), purine NTP-dependent helicase activity (3), atpase activity, coupled (4), atpase activity (4)
  8                                                                    0.95                                                               Enzyme binding (8), protein kinase binding (4), kinase binding(4)
  9                                                                    0.94                                                               Macromolecular complex assembly (11), macromolecular complex subunit organization (11), protein complex assembly (8), protein complex biogenesis (8), cellular macromolecular complex assembly (5), cellular macromolecular complex subunit organization (5), protein oligomerization (3)
  10                                                                   0.75                                                               Protein serine/threonine kinase activity (7), enzyme linked receptor protein signaling pathway (6), phosphate metabolic process (11), phosphorus metabolic process (11), protein kinase activity (8), protein amino acid phosphorylation (8), phosphorylation (9)

Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D12 of pregnancy compared with those on D12 of the estrous cycle.

Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.

The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.

###### 

Functional annotation clusters of down-regulated genes in uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle

  Annotation cluster[a](#tfn10-ajas-25-8-1102-7){ref-type="table-fn"}   Enrichment score[b](#tfn11-ajas-25-8-1102-7){ref-type="table-fn"}   Biological terms[c](#tfn12-ajas-25-8-1102-7){ref-type="table-fn"}
  --------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                                     1.68                                                                Adenyl ribonucleotide binding (15), purine ribonucleotide binding (17), purine nucleotide binding (17), ribonucleotide binding (17), nucleoside binding (15), adenyl nucleotide binding (15), purine nucleoside binding (15), ATP binding (14), nucleotide binding (18)
  2                                                                     1.50                                                                Cytoskeletal part (11), microtubule cytoskeleton (7), intracellular non-membrane- bounded organelle (18), non-membrane- bounded organelle (18), centrosome (4), cytoskeleton (13), microtubule organizing center (4)
  3                                                                     1.50                                                                Cytoskeletal part (11), dynein complex (3), microtubule associated complex (4), microtubule-based movement (4), microtubule cytoskeleton (7), motor activity (3), microtubule motor activity (3), microtubule (4), microtubule-based process (4)
  4                                                                     1.20                                                                Cytoskeletal part (11), regulation of actin filament length (3), regulation of cellular component size (5), regulation of actin cytoskeleton organization (3), regulation of actin filament-based process (3), regulation of organelle organization (4), actin cytoskeleton (4), cytoskeletal protein binding (6), regulation of cytoskeleton organization (3), actin binding (4)
  5                                                                     1.17                                                                Regulation of neuron differentiation (4), regulation of neurogenesis (4), regulation of nervous system development (4), regulation of cell development (4), neuron differentiation (4)
  6                                                                     0.92                                                                Protein amino acid dephosphorylation (4), dephosphorylation (4), phosphorus metabolic process (9), phosphoprotein phosphatase activity (4), phosphate metabolic process (9), protein tyrosine phosphatase activity (3), phosphatase activity (4), protein kinase activity (5), protein serine/threonine kinase activity (4), protein amino acid phosphorylation (5), phosphorylation (5)
  7                                                                     0.84                                                                Central nervous system neuron axonogenesis (3), central nervous system neuron development (3), central nervous system neuron differentiation (3), cell projection organization (5), cell motion (5), axonogenesis (3), cell morphogenesis involved in neuron differentiation (3), neuron projection morphogenesis (3), cell projection morphogenesis (3), cell morphogenesis involved in differentiation (3), cell part morphogenesis (3), neuron differentiation (4), neuron projection development (3), cell morphogenesis (3), cellular component morphogenesis (3), neuron development (3)
  8                                                                     0.82                                                                Regulation of synaptic transmission (3), regulation of transmission of nerve impulse (3), regulation of neurological system process (3), regulation of system process (4)
  9                                                                     0.75                                                                Cell projection organization (5), cytoskeletal protein binding (6), cytoskeleton organization (3)
  10                                                                    0.71                                                                Learning or memory (3), neurological system process (10), behavior (5), cognition (4)

Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D15 of pregnancy compared with those on D15 of the estrous cycle.

Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.

The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.

![Volcano plot images for the comparative analysis of endometrial gene expression on day (D) 12 of pregnancy to D12 of the estrous cycle (A) and on D15 of pregnancy to D15 of the estrous cycle (B) in pigs. The X axis represents the average log_2 (fold-change), and the Y axis represents the -log (p-value) with base 10. Location in the upper left shaded area implies down-regulation; location in the upper right shaded area implies up-regulation. Cutoff values were below p\<0.05 (horizontal line) and above an average two-fold change (vertical lines).](ajas-25-8-1102-7f1){#f1-ajas-25-8-1102-7}

![Functional annotation charts showing distribution of ontological analysis of up-regulated (A) and down-regulated genes (B) in the uterine endometrium on day (D) 12 of pregnancy compared with those on D12 of the estrous cycle, and up-regulated (C) and down-regulated genes (D) on D15 of pregnancy compared with those on D15 of the estrous cycle. Biological terms were identified by genes with respect to biological process at level one through DAVID. Gene ontology terms or biological features of differently expressed genes and the number of genes in each category are indicated.](ajas-25-8-1102-7f2){#f2-ajas-25-8-1102-7}

![Real-time RT-PCR analysis of selected differentially expressed genes, *ADAMTS20* (A), *MUC5AC* (B), *NRIP1* (C), and *RBP7* (D), in the uterine endometrium during the implantation period in pigs. Levels of *ADAMTS20* and *MUC5AC* mRNA were significantly different in the endometrium on D12 of the estrous cycle and pregnancy (p\<0.05). Levels of *NRIP1* mRNA were significantly higher in the endometrium on D15 of pregnancy than D15 of the estrous cycle (p\<0.05), but levels of *RBP7* were not different (p\>0.05). Abundance of mRNA is presented as the expression relative to the levels of *ADAMTS20*, *MUC5AC*, *NRIP1* and *RBP7* mRNAs measured in the uterine endometrium after normalization of the transcript amount to *RPL7* mRNA. Data are presented as means with standard error.](ajas-25-8-1102-7f3){#f3-ajas-25-8-1102-7}
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